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Mass media framing of biotechnology news
Leonie A. Marks, Nicholas Kalaitzandonakes, Lee Wilkins and Ludmila
Zakharova
In fast-changing scientific fields like biotechnology, new information and dis-
coveries should influence the balance of risks and rewards and their associated
media coverage. This study investigates how reporters interpret and report
such information and, in turn, whether they frame the public debate about
biotechnology. Mass media coverage of medical and agricultural biotechnol-
ogy is compared over a 12-year period and in two different countries: the
United States and the United Kingdom. We examine whether media have con-
sistently chosen to emphasize the potential risks over the benefits of these
applications, or vice versa, and what information might drive any relevant
changes in such frames. We find that the two sets of technologies have been
framed differently—more positive for medical applications, more negative for
agricultural biotechnology. This result holds over time and across different
geographic locations. We also find that international events influence media
coverage but have been locally framed. This local newsworthiness extends to
both medical and agricultural applications. We conclude that such coverage
could have led to differences in public perception of the two sets of technol-
ogy: more negative (or ambivalent) for agricultural, positive for medical appli-
cations. Our findings suggest that understanding news frames, and the events
that drive them, provides some insight into the long-term formation of public
opinion as influenced by news coverage.
1. Introduction
Few technologies have received as much news coverage as biotechnology. There are many
applications but two—medical and agricultural—have seen more attention. There is some
evidence that news media have been ambivalent about agricultural biotechnology and more
positive towards medical applications. Public attitudes towards agricultural and medical
biotechnology have seemed to mirror the news media’s stance. Certainly, publics have been
skeptical of biotechnology’s use in agriculture.1 In contrast, opinion polls regarding medical
biotechnology applications are globally more positive.2 Some have observed that perceptions
and attitudes about biotechnology might have been cultivated by media framing of its relative
risks and benefits: positive for medical, more negative for agriculture (Bauer, 2002). A review
of the literature does suggest a negative media view of agricultural biotechnology. Such a
view, however, has not been stable over time—positive early on, and more negative during the
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late 1990s (Priest and Talbert, 1994; Abbott and Lucht, 2000; Bauer, 2002; Bonfadelli et al.,
2002; Marks et al., 2002, 2003). The media coverage of medical biotechnology has not been
analyzed as extensively, though a small number of studies seem to suggest more positive
views (Bauer, 2002; Pfund and Hofstadter, 1981; Conrad, 1999).
We expect that in new and fast-changing scientific fields like biotechnology, new infor-
mation and discoveries would influence the balance of risks and rewards and their associated
media coverage. How then are such new discoveries and information used by the mass media?
Do reporters choose to emphasize more potential risks than potential benefits? Do they
choose to emphasize risks over benefits for certain applications over others? Do they interpret
and report differently information and thereby frame the public debate?
This study addresses these questions by comparing mass media coverage of the two sets
of biotechnology applications—medical and agricultural—over a 12-year period and in two
different countries—the US and the UK. In this context, we examine whether media have
consistently chosen to emphasize the potential risks over the benefits of these applications, or
vice versa, and what information might drive any relevant changes in such frames.
2. Can media shape public perceptions and attitudes toward biotechnology?
In many countries, the news serves as a primary source of risk communication to the general
public (Boholm, 1998). The news media may define the agenda of public concern about a
potential hazard. This process of mediated public attention is known as “agenda setting,” or
the concept that the media may not tell us what to think, but they tell us what to think about
(McCombs and Shaw, 1972: 177; Cohen, 1963: 13). The core theoretical assertion of agenda
setting theory is that the degree of emphasis placed on issues in the mass media adds salience
to such issues and influences the priority accorded them by the public (McCombs and
Ghanem, 2001: 67). Hence, the greater the volume and prominence of media coverage the
more important the public will evaluate the issue to be. Entman (1991) alternatively refers to
this process of the media lending overall salience to an issue as “sizing”: how much material
is available and how prominently it is displayed creates its importance. Issue salience or siz-
ing has been the focus of empirical examination in multiple cultures for the past 30 years and
has been found to apply to a variety of issues, including political campaigns and candidate
selection, public opinion about drugs and crime, and even about competing brands of goods
(Entman, 1991).
Developing in parallel with agenda setting theory is the idea that mass media not only
lend salience to an issue but frame the discussion around it. Tuchman (1976, 1978) has argued
that in reporting a story, journalists turn an occurrence into a newsworthy event, and a news-
worthy event into a story, which is then communicated to the public. Journalists and editors
employ frames according to their own understanding, while conforming to practical limita-
tions such as deadlines and space (Hornig, 1990). Writing on science and technology can thus
emphasize scientific facts, their sociopolitical implications, environmental risks, human
health concerns, and so on (Hornig, 1990). Through frames, media highlight certain points of
view and marginalize others, defining occurrences, and explaining how they are to be under-
stood (Hornig, 1993). A technology’s potential risk to the environment can be highlighted,
while its potential economic benefits might be ignored, or vice versa, depending upon the
story frame. In general, framing theory has not explicitly linked frames with opinion forma-
tion (McCombs and Ghanem, 2001).
Several scholars argue that the convergence of agenda setting and framing theories can
yield a greater unity in our knowledge of how the media’s picture of the world is constructed.
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These scholars (Lopez-Escobar et al., 1998; Kiousis et al., 1999; Golan and Wanta, 2001;
McCombs and Ghanem, 2001) suggest a framing effect whereby attribute salience is trans-
mitted to the public. Attributes may be defined as cognitive—concrete information about a
particular political candidate’s stand on specific issues for example—or affective, whether
a particular question is reported in a positive or negative light. It is this framing process that
these scholars suggest might ultimately influence public perception (McCombs and
Ghanem, 2001). How risks are framed can include elements of both cognitive and affective
attributes.
Entman (1991: 7) argues that such frames can be detected by probing for particular words
and visual images that consistently appear in a narrative, and which convey thematically con-
sonant meanings across media and time. He further argues that by providing, repeating, and,
therefore, reinforcing words that reference certain ideas but not others, frames work to make
some ideas more salient in the text, others less so and some invisible. Such repetition of words
and images renders one interpretation that is more readily discernible, comprehensible, and
memorable than others.
If risks are emphasized relative to the benefits of a technology, the theory predicts a
more negative sentiment on the part of the public. Yet, it is not only how much risks are
emphasized that influences public perceptions, but also how they are presented. Studies
have shown that most risks can be grouped in terms of the degree to which a risk is
“dreaded” and the degree to which a risk is “unknown” (Slovic, 2001). Findings in cogni-
tive psychology suggest that people have a tendency to overestimate unusual and spec-
tacular risks (such as bovine spongiform encephalopathy, tornadoes, and floods) and
underestimate familiar ones, such as cancer, strokes and heart disease. Hazards that are
more dramatic and spectacular may be more easily remembered and their higher cognitive
availability explains the tendency of subjects to overrate the risks of such hazards
(Kahneman and Tversky, 1984). Hence, the way risks are framed can influence how the
public might remember them and respond.
3. Biotechnology in the news
So how have media covered biotechnology? A number of studies have investigated media
coverage of biotechnology applications—mainly agricultural ones. Some observers argue that
media have been sensationalistic or outright anti-technology in their reporting. For instance,
Hoban (1995) noted that the mass media have been selective in their coverage of agricultural
biotechnology, more interested in politics than science, simplicity rather than complexity, and
danger rather than safety. It is possible, but such a hypothesis has not been demonstrated in
media studies. What does seem clear is that coverage of agricultural biotechnology has been
ambivalent rather than overly negative. Hagedorn and Allender-Hagedorn (1997) examined
media coverage of agricultural biotechnology (microbes, modified plants, animals and foods)
from 1987 to 1994. They found that the popular press did focus more on “social” risks asso-
ciated with biotechnology: health and ethical issues; value, nutrition, safety and labeling of
biotech foods; public safety and regulatory input.
Abbott and Lucht (2000) examined US and UK media coverage of agricultural biotech-
nology from 1997 to 2000. They found that reporting was initially positive but turned nega-
tive during the peak in media coverage in 1999. Frewer et al. (2002) investigated the effect of
increased media reporting of biotech foods from 1998 to 2000 on public attitudes. They did
not explicitly quantify frames employed, however.3 Marks et al. (2002, 2003) examined media
frames of genetically modified crops in US and UK newspapers, finding that environmental
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risks (e.g., “irreversible transgenes”) were emphasized over benefits (e.g., less pesticide use
and associated benefits to water quality, land savings, less impact on wildlife). Bonfadelli
et al. (2002: 118) found balanced to somewhat negative reporting of agricultural biotechnol-
ogy in Swiss newspapers from 1997 to 1999: 25 percent of articles reported risks only, 25 per-
cent both the risks and benefits, 21 percent benefits only, and 29 percent neither risks nor
benefits. Scientists, the most frequently sourced group (43 percent of all articles), held posi-
tions on both sides of the technology (p. 119).
In contrast, Pfund and Hofstadter (1981) found that industrial rather than academic
interests set the terms of discussion in media coverage of “recombinant DNA” (medical) in
the late 1970s, implying more positive framing of biotechnology news.4 Priest and Talbert
(1994) found that over 70 percent of biotechnology (both medical and agricultural) sources
used were experts (either industry or scientists) in the early 1990s and framing was gener-
ally more positive.5 In reporting of genetics (medical) news in several US newspapers,
Conrad (1999: 294) found that 49 percent to 80 percent of sources used were expert scien-
tists. Conrad (1999) argues that the initial source for many science news stories is the prin-
cipal author of a breaking journal article published in elite scientific journals. Moreover,
some science reporters may assume that a particular scientific finding does not require “bal-
ance” because science has already gone through a peer-review process (Conrad, 1999).
From this viewpoint, one might expect more positive framing in reporting of medical
biotechnology.6
Bauer (2002) is the only study, that we are aware of, that has systematically compared
reporting of agricultural and medical applications of biotechnology over an extended time
period. He investigated media coverage in the UK press from 1973 to 1999. He used four
frames: prospect, concern, fait accompli, and the degree of risk–benefit. He also found more
positive framing of biotechnology applications in UK media during the 1970s and 1980s and
he concluded that the media cultivated an observed split in UK opinion—more positive for
medical, negative for agricultural during the 1990s.
Clearly, some people have suggested that media have been (unduly) negative. However,
empirical findings from biotechnology media studies suggest that the negative stance of the
media has fluctuated over time: prior to the late 1990s some studies have documented a more
positive framing of biotechnology applications including agricultural ones (Pfund and
Hofstadter, 1981; Priest and Talbert, 1994; Bauer, 2002). However, later studies have shown
that at the height of public debate, agricultural biotechnology coverage, at least, became more
negative (Abbott and Lucht, 2000; Marks et al., 2002, 2003; Bauer, 2002). On the other hand,
coverage has generally been more positive for medical applications. However, it is still
unclear whether such focus is due to an undue emphasis on agbiotech potential risks or lack
of attention on potential benefits. Do reporters choose to frame agricultural and medical
biotechnologies differently? How is such potential framing related to new information that
becomes available on these technologies over time?
4. Research design
With an emerging scientific technology one should expect new information to become avail-
able which could potentially alter the agenda. Such information might be of various kinds:
major discoveries and technological milestones; commercialization experiences; new regula-
tions or changes to existing regulations; or possible previously unknown risks or benefits
revealed by a credible source. The risk–benefit ratio employed in coverage could be altered
by such information. For example, as a technology is commercialized its actual benefits
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may become more clear; regulatory and other rules of conduct could be broken revealing
unforeseen risks (e.g., Starlink). Major institutional changes, for example, mandatory label-
ing of the technology, could also signal an informational change and therefore a change in the
risk–benefit ratio. All such events would enhance information and knowledge. Such events
not only could give a reason for increased coverage but, importantly, could change the way
risks and benefits are framed.
In order to examine empirically what might explain volume and potential changes in the
risk–benefit ratio in biotechnology reporting in this study we record how such risk–benefit
ratios are framed over a 12-year period. A longitudinal study of framing effects captures the
dynamic “frame-changing” process of news coverage whereby the media can reframe the dis-
cussion of a public issue over its lifespan (Chyi and McCombs, 2004: 22).7 We then examine
the relationship of how the flow of new information has affected the volume and risk–benefit
ratio of such coverage. Coverage is compared across two different countries: the United
Kingdom and the United States. We examine coverage in UK and US media given their recent
differing experiences with the technology.8 While cross-country analyses are difficult to con-
duct (Livingston, 2003) they can nevertheless yield important insights (i.e., detection of any
similarities and/or differences) in media frames employed and possible agenda setting effects
(Gurevitch, 1989; Blumler et al., 1992; Peter, 2003; Livingston, 2003). Indeed, as Gurevitch
(1989) suggests such analyses can contribute to the expansion of data in order to make more
solid generalizations; alternatively they can provide important counters based on naive
assumptions of universality.
We also systematically compare coverage across the two different applications of
biotechnology. As the same genetic engineering techniques underlie the various applications,
of biotechnology (Jenkins, 1998), they present an opportunity to investigate media narratives
about them, and how these might influence perceptions. In this way, any similarities and dif-
ferences in media frames can be detected. As Entman (1991: 6) points out, unless narratives
of similar phenomena are carefully compared, news frames can be difficult to detect fully and
reliably. Such comparisons can reveal the way in which news frames help establish a
“common sense” or widespread interpretation of events, or, in the case of this study, of com-
plex technologies, such as biotechnology (Entman, 1991: 6).
In order to make meaningful comparisons among the two sets of biotechnology applica-
tions we chose three different medical applications to compare with agricultural coverage:
human cloning, xenotransplantation, and gene therapy. To the extent that the literature docu-
ments that agricultural biotechnology is controversial,9 these applications were chosen as they
have also been associated with some degree of controversy, albeit less so, and they therefore
provide an opportunity to explicitly test whether reporters have been more or less balanced in
their reporting of medical versus agricultural applications.
Human therapeutic cloning involves both potential benefits and risks. Possible benefits
of cloning (animal, human cell) include the production of biopharmaceuticals (where cloned
animals produce pharmaceuticals for the treatment of human diseases); preservation of
endangered species (where rare animals could be saved from extinction); and production of
“personalized” stem cells for treating diseases (e.g., when a suitable bone marrow donor can-
not be found) (Marchione, 1998). Detractors have argued that human cloning would lead to
“armies of cloned slaves” or the marketing of “perfect” children (Williams, 1998). Also,
cloning presents possible health risks, for example, Dolly the sheep’s telomeres were discov-
ered to be old in September 1997, and subsequently there have been concerns about Dolly’s
early aging.
Gene therapy is an approach for treating disease by either modifying the expression of an
individual’s genes or correcting abnormal genes (American Society of Gene Therapy, 2000).
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Several genetic diseases are candidates for gene therapy including cardiovascular disease,
cancer, and autoimmune and infectious diseases, such as AIDS and hepatitis. Possible risks
of gene therapy include over-expression of a missing protein, causing harm to the patient;
inflammation or immune reaction to the viral vector used to express the gene; and transmis-
sion of viral vectors from the patient to other humans and the environment (National Cancer
Institute, 2000). And at the extreme it can result in fatality.
Xenotransplantation involves the use of animal organs or tissue transplants to replace
human parts. Potential benefits of xenotransplantation include an alleviation of human donor
organ shortages, and the production of cells and tissue to treat diseases. “Xenografts” are
genetically modified to be more human-like in order to prevent hyperacute rejection of the
organ by the human body. Risk is typically viewed on an individual basis during clinical tri-
als. However, there are several other concerns, such as infection (spread of animal retro-
viruses to humans) (Institute of Medicine, 1996).
Agricultural biotechnology has been used to produce higher crop yields, and, hence
lower cost of the food supply, plants that are naturally protected from disease and insects, and
potentially more nutritious and better tasting foods. Potential environmental benefits include
reduced pesticide use and employment of soil saving cropping methods. Perceived envi-
ronmental risks include “uncontrollable” or “irreversible” escape of transgenes with potential
consequences for biodiversity, wildlife, and ecosystems. Potential food safety risks include
possible “allergic reactions” to modified proteins. Crops produced through biotechnology are
already significant components of the US and international harvest—especially for some key
commodities. These include soybeans, corn, cotton, canola, and papaya. Most biotech foods,
such as herbicide-tolerant soy and Bt-corn are used in animal feeds and in the production of
ingredients for processed food products. Hence, all four medical and agricultural applications
have been associated with potential health risks and benefits for individuals and society as a
whole. Individual risks from medical applications include “dreaded” health risks; as well as
ethical and moral risks. Potential catastrophic health risks include the “unintended” introduc-
tion of viruses into the human population from xenotransplantation and gene therapy.
Similarly, agricultural biotechnology has evoked the potential for “catastrophic” effects in
wild populations and “dreaded” and “unknown” health risks for future generations.
5. Analysis of media frames
We employ content analysis to investigate possible risk–benefit frames. A comprehensive
database of newspaper articles relating to medical and food applications of biotechnology,
published in the London Times, the Sunday Times and the Washington Post, was developed
from an exhaustive list of key-words. The Lexis Nexis and Factiva electronic databases were
searched. We chose national daily newspapers comparable in circulation size.10 The search
resulted in 750 articles pertaining to the three medical applications of biotechnology, and
1,251 articles relating to agrobiotechnology coverage.
Categorization and coding of the data
We use Slovic’s (1987) heuristic to identify reporting of “dreaded” risks versus the relative
“benefits” of biotechnology. In order to operationalize dreaded risk, we utilized two cate-
gories of his psychometric model, namely, “catastrophic” and “memorable” risk. One vari-
able resulted from these two factors, as risks can be either catastrophic or memorable or both.
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For example, Chernobyl was mentioned in media reports on agricultural biotechnology.
Chernobyl is clearly a memorable event—it gained worldwide media coverage and attention,
and is likely to be easily recalled by the general public. Likewise, Chernobyl has the conno-
tation of being “catastrophic” to the general population in its immediate vicinity and to world
populations and ecosystems. In most cases the two sets of risks overlap and were coded together.
The Starlink food recall is considered a “memorable” but not a catastrophic risk event—given
the minimal risk of allergic response attached to it by the US regulatory agencies and the
Center for Disease Control (CDC). As we found that the majority of the codes in the dictio-
naries developed below indicated overlap between the two categories, they were combined
into one variable.
Specific memorable risk events linked to agricultural applications include “Chernobyl,”
“Bhopal,” the “Exxon Valdez,” “Three Mile Island,” “Times Beach,” the “extinction of the
Dodo,” “the mad cow disaster,” “dioxin scare,” “Jack-in-the-Box scare,” and so on. Memorable
risk events linked with medical applications include reference to “Aldous Huxley,” “Hitler,”
“holocaust,” “eugenics,” “Baby Fae,” “Boys from Brazil,” and so on. Catastrophic risks linked
to both medical and agricultural coverage include phrases such as, “nightmarish,” “calami-
tous,” “catastrophic scenarios,” “cause ecological disaster,” “catastrophic for human health,”
“cause infectious epidemic,” “cause extinction,” “destroy the environment,” “Pandora’s box,”
“armies of clones,” and so on.
All-inclusive categories of benefits were also developed for each of the applications.
Agricultural biotechnology benefits were defined to include: health, environmental, eco-
nomic, social, and humanitarian benefits associated with agrobiotechnology applications.
Medical benefits were defined to include any type of disease that might be alleviated by the
use of the medical intervention, more efficient techniques for detecting and treating disease,
and more targeted and potent, cost-effective therapies for treating diseases.
Coding scheme
Both manual and electronic coding can be used to conduct content analysis. Electronic con-
tent analysis saves time, eliminates the need for multiple human coders, and accommodates
large datasets. It offers more flexibility to investigators because dictionaries can be more eas-
ily modified and reapplied to the same texts. It also provides greater reliability because it
removes human errors due to fatigue or changes in understanding of coding rules. However,
if a category is complex, wide-ranging, and inclusive then manual coding may be necessary
(Lee, 1997). Because of our sample size, we used computer-aided analysis to quantify the
variables under study.
In developing the dictionaries, we used a two-step procedure. Two human coders manu-
ally coded a stratified random sample of articles (n = 127)11 from the entire population of arti-
cles. This approach allowed the researchers to test the reliability (consistency and validity) of
the variable definitions. We use Krippendorf’s alpha as a measure of reliability. This measure
accounts for variation in interval and ratio level data. Common standards for what consti-
tutes an acceptable level of agreement for intercoder reliability statistics are not in place
(Neuendorf, 2002). Acceptable measures of agreement fall in the range of 0.70 to 0.90
(Krippendorf, 1970; Banerjee et al., 1999; Riffe et al., 1998). However, beyond-chance sta-
tistics, such as Krippendorf’s alpha and Scott’s PI, are afforded more liberal criteria than more
simple measures (Neuendorf, 2002: 143). The initial level of agreement (Krippendorf’s
alpha) for the manual coding ranged from 0.73 to 0.91 for the benefits variables and 0.80 to
0.91 for the risk variables.
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The levels of agreement achieved by the two human coders were considered acceptable
for further refinement of definitions and development of dictionaries of words and word
phrases relating to the conceptual categories (measured by our operational definitions) that
were constructed. Words “before” and “after” the word or phrase included in each category,
or key-word-in-context (KWIC) analysis, were used. Development of the variables (dictio-
naries) involved an iterative process.12 Once the initial list of words and phrases had been
developed, computer generated key-words-in-context lists were used to determine which
words and phrases contained in the draft dictionaries were accurate indicators of the variable
in question. Following the approach of Bengston and Xu (1995) and Marks et al. (2003),
the dictionaries were refined until words or word phrases were used correctly 80 percent (or
greater) of the time across the entire population of articles.
Results
Frequency of coverage
Figures 1 and 2 detail the coverage of the two applications by number of articles. Agricultural
biotechnology received the most coverage in both newspapers from 1990 to 2001. However, it
received far more attention in the UK than in the US during 1999 and 2000 as indicated by the
spike in overall coverage. Medical coverage also increased during the 1990s. We find the height
of public debate, as reflected in agricultural coverage, to be 1999 which was roughly four times
that of medical coverage in the London Times and two times higher in the Washington Post.
Differences in risk–benefit frames
We find that international coverage of biotechnology has emphasized the agricultural risks
significantly more than its medical ones. Tables 1 and 2 report frequencies of words or word
phrases related to each variable by application. For the Washington Post, we find the propor-
tion of benefits/risks is significantly higher, χ2 = 135.61 (1 df, p > 0.001), for medical cover-
age (1.98:1) than agbiotech coverage (0.86:1). This result is mirrored for the London Times,
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Figure 1. US and UK coverage of medical applications of biotechnology.
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Table 1. Washington Post coverage, 1990–2001
Benefits Dread risksa
Washington Post (words / word phrases) (words / word phrases)
Agbiotech 574 670
Food safety 429 426
Environmental 145 244
Medical 1445 728
Gene therapy 671 480
Human cloning 594 159
Xenotransplantation 180 89
a Dread risks refer to “catastrophic” risks and “memorable events” categories of the psychometric paradigm. 
Table 2. London Times coverage, 1990–2001
Benefits Dread Risksa
London Times (words / word phrases) (words / word phrases)
Agbiotech 621 598
Food Safety 505 317
Environmental 116 281
Medical 1253 309
Gene therapy 493 77
Human cloning 556 158
Xenotransplantation 204 74
a Dread risks refer to “catastrophic” risks and “memorable events” categories of the psychometric paradigm. 
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Figure 2. US and UK coverage of agricultural biotechnology.
χ2 = 266.98 (1 df, p > 0.001), with medical benefits exceeding risks (4.06:1), as opposed to
agricultural biotechnology (1.04:1). Inter-country comparisons by application indicate that
the Washington Post has generally been more negative than the London Times. In pairwise
comparisons, the Washington Post emphasized the environmental and food safety risks of
agricultural biotechnology more than the London Times did, χ2 = 5.68 (1 df, p > 0.017) for
the entire time period (1990–2001). The Washington Post was significantly more negative in
its coverage of all medical applications taken together than the London Times was, χ2 = 85.29
(1 df, p > 0.001).13 However, the two papers were not significantly different in their reporting
of human cloning (χ2 = 0.222, 1 df, p > 0.637) and xenotransplantation (χ2 = 2.733, 1 df, p >
0.098) at a conventional level. Our findings support the overall negative framing of agrifood
biotechnology that has been found in previous studies, and show strong positive framing of
medical applications across the entire period. But how are such frames drawn by media? And
how do they change over time in response to specific informational events?
6. Framing of hazard events
To answer these questions we examined how relevant informational milestones affected the
cycle of coverage and framing (risk–benefit ratios) of the two sets of technology. A number of
milestones may have influenced how reporters have covered stories of biotechnologies over
time. We list such major commercialization and potential hazard events in Table 3. Recombinant
bovine growth hormone (rBGH) was approved by the Food and Drug Administration in 1993 to
increase the amount of milk produced by treated cows. Potential benefits of rBGH include an
increase in the milk supply and a price reduction for consumers. However, cows treated with
rBGH can produce milk with higher levels of insulin-like growth factor 1 (IGF-1). Insulin-like
growth factor 1, produced by humans as well as cows, plays a necessary role in many bodily
functions. As a result, there were calls for mandatory labeling of dairy products from rBGH-
treated cows. In 1994, Flavr Savr tomatoes were one of the first crops to be commercialized in
the United States. Flavr Savr promised to be a new “designer crop” enhanced to improve taste
and have a longer shelf-life. While Flavr Savr promised direct consumer benefits, potential risks
of pollen transfer of foreign, implanted genes to wild plants or other crops were considered at
the time of its introduction. In 1999, John Losey and colleagues published a laboratory study
that indicated that monarch butterflies could be harmed by biotech corn pollen. Although the
study’s findings indicated only a potential hazard it indicated a potential and previously unan-
ticipated risk and garnered international media attention. In May 2000, imported conventional
canola seeds in the UK were found to contain some genetically modified (GM) seed that had
not been approved for commercialization in European markets at the time. UK farmers unknow-
ingly planted and multiplied them in their fields.
In the UK during 1998, Dr. Arpad Pusztai went on national television stating that biotech
potatoes fed to laboratory rats had caused severe damage to their organs and overall develop-
ment. While Dr. Pusztai’s study was generally discredited by mainstream scientific societies,
and his own research institute, it was subsequently published as a Research Letter in The
Lancet (Ewen and Pusztai, 1999). In the United States, on the other hand, the commingling of
the food supply with Starlink (a biotech corn feed approved for animal consumption only) led
to recalls of multiple affected products. A highly reported fatality resulting from an experi-
mental gene therapy trial took place in the United States in 1999—the case of Mr. Jesse
Gelsinger. Dolly the sheep sparked controversy (over the possibility of human cloning) but also
promised to deliver major benefits through the production of drugs manufactured by animals
and from xenotransplantation. The Human Genome Project opened up vast potential for new
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discoveries in human health and agricultural production, but also highlighted the potential for
individual risks (e.g., “inappropriate” use of genetic information by insurance companies).
Regression analysis
We examined the relationship between framing of potential hazard events and the aforemen-
tioned informational milestones through regression analysis. The effects of these events on
reporters’ frames are modeled through a system of seemingly unrelated regressions (SUR)
given that the error terms may be correlated across newspapers and, therefore, estimation effi-
ciencies are possible. We use generalized least squares estimation correcting for first-order
autocorrelation where detected. Our empirical model is as follows:
DIFi = αi + β1i ∗ ΜΟΝ + β2i ∗ GMC + β3i ∗ PUS + β4i ∗ STAR + β5i ∗ BGH +β6i ∗ FLAVR + β7i ∗ DOLLY + β8i ∗ HGP + β9i ∗ GTEXP + β10i ∗ ΤΙΜΕ + µi (1)
where MON, GMC, PUS, STAR, BGH, FLAVR, DOLLY, HGP, and GTEXP represent (prede-
termined) event variables related to the monarch butterfly (MON), the commingling of conven-
tional canola seed with genetically modified seed (GMC), the report of Dr. Pusztai’s study
(PUS), the Starlink recall (STAR) in the United States, the introduction of bovine growth hor-
mone (BGH) into the US milk supply from 1995 onwards, the brief introduction of the Flavr
Savr tomato (FLAVR) into US markets in 1994, “Dolly the sheep” (DOLLY), the Human
Genome Project (HGP) and the case of Mr. Jesse Gelsinger (GTEXP). Each event variable is
measured by coverage in each newspaper. These event variables are regressed on the dependent
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Table 3. Biotechnology events (1990–2001)
Dates of beginning Variable 
Event coverage name Description
Bovine Growth January 1994 BGH Bovine Growth Hormone (BGH) or rBST
Hormone approved and marketed in the United States
Dolly the sheep February 1997 DOLLY Dolly is born
June 1997 Human cloning banned in US
September 1997 Dolly’s telomeres are found to be old
Flavr Savr tomato April 1994 FLAVR Flavr Savr tomato approved and marketed
in the United States
GM Contamination May 2000 GMC UK imports of canola (rapeseed) found to
contain biotech seeds which farmers
planted unknowingly in their fields
Human Genome April 2000 HGP Human genome mapped garnering worldwide
Project attention and commercial optimism
Monarch butterfly May 1999 MON John Losey et al. publish lab study results 
indicating monarch butterflies are
harmed by GM corn pollen
Philadelphia September 1999 GTEXP Mr Jesse Gelsinger dies from controversial 
experiment experimental gene therapy conducted at 
University of Pennsylvania, Philadelphia
Pusztai report August 1998 PUS Dr Arpad Pusztai goes on UK national
television saying that GM potatoes fed to lab
rats caused serious harm to their organs
and health
Starlink September 2000 STAR US food supply commingled with Starlink
corn approved for use in animal feed only
variable DIFi which measures absolute differences in reporting the benefits and risks of each
application of the technology (medical and agricultural) in each (ith) newspaper, namely, the
London Times (LT) and the Washington Post (WP). A time trend variable (TIME) is also
included in each regression.
The empirical model is estimated using 144 consecutive months of data for each news-
paper, with zeros substituted at the appropriate dates for non-existent coverage. This assumes
that there is no qualitative difference between non-coverage and coverage where reporters
chose not to report either risks or benefits associated with agricultural and medical applica-
tions of biotechnology. Some events were not covered by national newspapers. For example,
in the case of agbiotech coverage the London Times did not run the Starlink story during the
period of coverage (despite its international significance). Interestingly, other UK newspa-
pers, such as the Guardian, the Financial Times, and the Independent did allocate space to
Starlink.
Results
The results from two sets of regression models are reported in Table 4. The monarch but-
terfly event is associated with a strong risk frame in both countries. In this case, the orig-
inal study by John Losey and colleagues was published in the prestigious journal Nature
and was therefore highly newsworthy (Conrad, 1999; Mazur and Conant, 1978; Mazur,
1984, 1989; Singer and Endreny, 1993). Nevertheless, the monarch butterfly story was the
only event that was framed in the same way across the two countries. The London Times
reporting of the commingling of GM canola with conventional seed was also found to be
negative—the commingling occurred at a time when debate was already heightened.
Starlink was associated with an emphasis on the potential food risks of agricultural
biotechnology, but only reported in the Washington Post, and other food safety events were
mostly insignificant in explaining tone of coverage. For example, both the benefits and
risks of biotechnology were equally reported during the “Pusztai affair”—effectively lead-
ing to balanced coverage in both countries. While some studies have concluded that the
Pusztai affair sparked a more negative debate (Frewer et al., 2002), this is not reflected in
our results. The research of Dr. Arpad Pusztai coincided with a significant increase in
reporting of environmental benefits and risks in the London Times with an emphasis on
benefits over risks. One possible explanation for this result, therefore, is that the work of
Dr. Pusztai broadened the debate: proponents and opponents both aired their viewpoints
in the media and the debate broadened to include other non-food safety issues, such as
environmental ones (Marks et al., 2003).
FLAVR was significant in explaining a positive frame in agricultural coverage in the
Washington Post. Hence, US reporters chose to emphasize the benefits and “potential” of new
biotech foods with “enhanced taste and textures” over possible risks. DOLLY and the HGP
were positively framed by London Times reporters in their coverage of medical biotechnol-
ogy. On the other hand, DOLLY was covered with a more negative frame by Washington Post
reporters reflecting the more contentious debate over human cloning that took place in the
United States.
The fatality of Mr. Gelsinger did significantly influence reporting of the risks associated
with gene therapy in the Washington Post explaining a large part of the variation. However,
his death was framed as a local story and was not significant in explaining gene therapy cov-
erage in the London Times. Only three out of 123 (2.4 percent) stories in the London Times
mentioned Jesse Gelsinger, compared to 22 percent of gene therapy stories in the United
States.
194 Public Understanding of Science 16(2) 
7. Discussion and conclusions
Risk perception is an important social and psychological phenomenon that influences deci-
sion-making at various levels of democratic societies. Understanding how the media have
portrayed the relative risks and benefits of different applications of biotechnology is impor-
tant to understanding how public perceptions are formed.
There are some interesting conclusions from our analysis. First, media have distinguished
between different applications of biotechnology on the basis of its relative risk and benefit ratio
that constitutes frames employing affective elements. In particular, medical applications of the
technology have been portrayed more favorably than agricultural ones in mass media coverage
across the two countries in this study. Media have highlighted the dreaded aspects of agricultural
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Table 4. Effect of events on biotechnology reporting by country and newspaper.
Agbiotechnology Medical
London Washington London Washington 
Times Post Times Post
Variable LTAG_DIF WPAG_DIF LTMED_DIF WPMED_DIF
Intercept –0.8827 –0.817 –0.366 1.65
(–0.841) (–0.774) (–0.216) (0.844)
MON –1.397 –0.595 — —
(–4.914)*** (–3.532)***
GMC –0.797 –2.038 — —
(–4.721)*** (–1.422)
PUS –0.169 2.25 — —
(–1.141) (1.951)
STAR — –1.028 — —
(–22.521)***
BGH –0.571 0.024 — —
(–1.274) (0.435)
FLAVR –0.737 0.623 — —
(–0.881) (2.131)**
DOLLY — — 0.785 –0.515
(3.306)*** (–2.01)**
HGP — — 2.865 0.186
(2.861)*** (0.519)
GTEXP — — –2.559 –0.51***
(–0.73) (–6.52)
TIME 0.036 0.039 0.068 0.049
(2.885)*** (2.902)*** (2.93)*** (1.99)**
AR(1) — — — —
Adjusted R2 0.27 0.79 0.25 0.22
DW statistica 1.93 1.72 1.84 2.21
a DW statistic for untransformed model. 
Notes: ** statistical significance at 5%, level; *** statistical significance at 1% level. Numbers in parentheses are
t-values.
biotechnology more than those of medical coverage, a framing process that because it includes
an affective component may influence public perception. Whether, in fact, such balance is justi-
fied on the basis of available evidence of harm is not so clear.
Second, while medical applications received much more favorable coverage, they have
also received their share of controversy and public scrutiny. The death of Mr. Gelsinger
strongly influenced reporting of gene therapy in the United States during 1999 and 2000. This
was a newsworthy event that, as it turns out, had greater local significance. The reporting
focused on an individual death and framed the risk from the individual point of view. Unlike
coverage of agricultural biotechnology, news coverage about Mr. Gelsinger did not amplify
the risk to all sorts of medical interventions with multiple populations. While the negative
frame surrounding Mr. Gelsinger’s death and its connection with gene therapy was not
repeated in the UK, other applications of the technology, such as therapeutic human cloning,
did not escape controversy either.
Human cloning generated considerable debate and international attention during 1997
when Dolly the sheep was first cloned. Subsequently, there was a call for an immediate ban
on human cloning in the United States and stem cell research and its implications for the
cloning of human embryos has been heavily debated since 2001. Priest (2001) notes that
Dolly shifted the US debate about biotechnology to one that explicitly incorporated ethical
considerations. We find that Dolly clearly sparked a more contentious debate in the United
States. In contrast, in the United Kingdom, the cloning of human embryos for research pur-
poses has been given the green light. Reporters in the UK (the country that developed the
technology) took a more positive stance on Dolly. In other words, we find that the debate
about Dolly, while internationally highly significant, was again locally framed.
Moreover, we find that Starlink, monarch butterfly, and GM canola all led to a more neg-
ative frame being employed. However, only in the case of the monarch butterfly was report-
ing consistently negative across the two countries. Once again the local focus in reporting is
apparent. The London Times chose not to cover Starlink but the GM canola story was locally
significant. Gene therapy coverage was strongly influenced by the gene therapy experiment
in the United States only. On the other hand, the development of Flavr Savr tomatoes was pos-
itively framed in US media reports. Hence, it is the “local factor” (Singer and Endreny, 1993:
68) that makes specific biotechnology events more newsworthy. We find some support for the
hypothesis of Galtung and Ruge (1965: 68): that is, the more an event concerns both nations,
the more probable that it will become a news item, although this result is not universally sup-
ported.14 Instead, we find that the local factor turns into national rather than international
framing of news events. This result is unexpected given an internationally conducted debate
and increasingly global media (Livingston, 2003; Hachten, 2005).
Fourth, we find that information on potential risks and, particularly negative events
(monarch butterfly, gene therapy experiment) drive frames. However, interestingly the very
same event can be framed differently, in the case of Dolly. The local focus and selective use
of the same information by reporters provides the strongest evidence yet that media can
frame and might have actively framed agricultural and medical biotechnology, and the
public debate through its coverage. It is of course difficult, and beyond the scope of this
paper, to demonstrate that such reporting could have directly influenced public perception
of agricultural and medical biotechnologies15 during the 1990s. However, some general
inferences can be made. Figures 3 and 4 detail how public opinion of biotechnology has
evolved over the time period investigated. These data are assembled from the Eurobarometer
surveys conducted in 1991 to 2002 (EC, 1991, 1993, 1997, 2000, 2003) and from the
International Food Information Council (IFIC, 2002) for the United States. The format of
the questions varies slightly over the five surveys investigated for the UK case,16 and the
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correspondence of the medical and agricultural biotechnology covered in our study and
their series is not complete. Nevertheless, Eurobarometer has consistently tracked public
opinion of biotechnology used in genetic testing, crop production, foods and, to a lesser
extent, vaccines. For brevity, we report opinion on genetic testing (proxy for medical) and
biotech foods only.
From these series, changes in the volume and tone of agricultural biotechnology cover-
age in the London Times coincide with a negative shift in UK public opinion. Similarly, a
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Figure 3. UK public opinion of biotechnology applications (1991 to 2002).
Note: Genetic testing question: “And what do you think of using genetic testing to detect diseases
we might have inherited from our parents such as cystic fibrosis, mucoviscidosis, thalassaemia?”
Biotech foods question: “Use of modern biotechnology in the production of foods, for example to
make them higher in protein, keep longer or change the taste…” Possible responses are “agree,”
“somewhat agree,” “disagree,” “somewhat disagree,” or “don't know” to whether “Such research is
worthwhile and should be encouraged.” Responses represented are “net,” i.e., the degree to which
the respondents agree with the statement minus the degree to which respondents disagree with the
statement.  Source: European Commission (1991, 1993, 1997, 2000, 2003), question format varies
slightly by year.
more positive perception of medical biotechnologies than agricultural ones among the gen-
eral public coincides with the strong positive framing of medical biotechnology during the
1990s (Figure 3). Volume of medical and agricultural coverage are both negatively correlated
over time with US public opinion of biotechnology also.17 As usual, correlations do not nec-
essarily imply causality but these aggregates suggest no inconsistencies in the hypothesis that
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Figure 4. (a) US public opinion of biotechnology benefits (1997 to 2002) and (b) US public willing-
ness to purchase biotech foods (1997 to 2002). Possible responses are “yes”, “no” and “dont know”.
Note: (a) Response based on the following question: “Do you feel biotechnology will provide ben-
efits for you and your family within the next five years?” Source: IFIC (2002).
(b) Based on the following question: “All things being equal, how likely would you be to buy a
variety of produce, like tomatoes or potatoes, if it had been modified by biotechnology to taste
better or fresher? Would you be very likely, somewhat likely, not too likely, or not at all likely to
buy these items?” Source: IFIC (2002).
media framing of biotechnology could have influenced public perception over the period of
analysis.
In summary, we find that the two sets of technologies have been framed differently. This
result holds over time and across different geographic locations. We also find that interna-
tional events have been locally framed (for the most part). This local newsworthiness extends
to both medical and agricultural applications. Similar to Bauer (2002) and Frewer et al.
(2002) we also conclude that such coverage could have led to differences in public perception
of the two sets of technology: more negative (or ambivalent) for agricultural, positive for
medical applications. Public opinion formation and acceptance should not be reduced to a
simple mirror of news reports. However, our findings suggest that understanding news
frames, and the events that drive them, provides some insight into the long-term formation of
public opinion as influenced by news coverage.
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Notes
1 Support for biotech crops and foods has been slightly lower than for medical applications in US opinion polls
(IFIC, 2002), and more so in Europe (European Commission, 1991, 1993, 1997, 2000, 2003). Several scholars
have suggested public ambivalence towards biotech foods (Select Committee, 2003; Marris et al., 2001; Petts et
al., 2001). Ambivalence is generally defined as “simultaneous and contradictory attitudes and feelings towards
an object” (Webster’s Collegiate Dictionary). By this definition, all applications of biotechnology exhibit some
degree of ambivalence on the part of various publics. In opinion research it has been defined more narrowly to
include a sub-group of respondents who “neither agree or disagree,” or “have no opinion,” on any given ques-
tion asked (Select Committee, 2003). By this definition some European countries, such as the UK, have exhib-
ited a higher level of ambivalence toward biotech foods than the US.
2 For example, in recent polls medical applications (vaccines, genetic testing) of biotechnology are typically twice
as likely to be accepted in the United Kingdom (UK) as improved crop varieties or biotech foods (European
Commission, 1991, 1993, 1997, 2000, 2003). The United States (US) has exhibited a similarly high level of sup-
port for human genetic screening (74–80%) and new vaccines (80%) (Hoban and Miller, 1998; Priest, 2000).
3 Their study focused on assessing the degree to which the mass media had amplified the risks associated with
food biotechnology during the height of media coverage. Therefore, the focus of their data collection and
analysis was three surveys conducted prior to the peak in UK coverage (February 1998), during the height of
coverage (March 1999) and post-peak (July 2000). They conclude that perceptions of risk associated with
biotech foods increased during the highest levels of reporting but were subsequently reduced as reporting lev-
els diminished.
4 Pfund and Hofstadter (1981: 144) present data with the newspaper or magazine as the unit of measurement.
Moreover, they quantify whether the newspaper or magazine included, “at least one mention of benefits and risks
of recombinant DNA research” only. It is therefore difficult to definitively conclude the degree of positive or neg-
ative framing with such an aggregate approach.
5 Although Priest and Talbert (1994: 81) conclude that media coverage was predominantly positive in tone, the
data presented on message content are not explicitly broken down by agricultural and medical applications.
6 However, Conrad did not explicitly code for positive (benefit) or negative (risk) messages so it is hard to con-
clude definitively.
7 Our coverage extends 2 years beyond the peak of public debate which occurred during 1999 in the United
Kingdom. Reporting in subsequent years (2002–2005) is about one-third to one-half lower than in 1999.
8 Given opinion data suggest greater ambivalence on the part of the UK public towards agricultural applications
of the technology, such a comparison allows for possible detection of differences (if any) in media reporting as
a possible factor in the formation of such opinion.
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9 We define controversy to be a public dispute between two sides holding opposing views.
10 UK newspapers are highly differentiated. We therefore do not assume that the London Times coverage is neces-
sarily representative of all UK newspapers. Similarly, for the United States.
11 Fifty articles are considered a minimum for reliable sub-samples (Neuendorf, 2002).
12 Phrases were developed as part of the manual coding exercise. These were incorporated as a baseline in our dic-
tionaries. The dictionaries were further refined across the entire population of articles.
13 This finding is explained by a focus on the case of Mr. Jesse Gelsinger (discussed in the next section). However,
a finding of more negativity on the part of Washington Post than London Times reporters is less expected. In other
work, we have found the Washington Post to be more negative than other US newspapers in its coverage of agri-
cultural biotechnology (Marks et al., 2002, 2003). Hence, caution is needed in generalizing beyond the newspa-
pers analyzed here.
14 For example, the London Times chose not to report Starlink. Elsewhere, Marks et al. (2003: 11) document that
the Daily Telegraph also chose not to run the Starlink story. However, other British newspapers did run the story
including the Guardian, the Financial Times, and the Independent.
15 Our opinion data are stronger in the UK case: the different applications have been consistently tracked since the
early 1990s. US opinion surveys are more fragmented and often the survey question does not delineate between
medical and agricultural applications. Nevertheless, we use the IFIC (2002) tracking survey which has tracked
opinion broadly on “biotechnology” and willingness to purchase biotech foods in particular.
16 For example, in the case of crop biotechnology, in 1991 and 1993 the question was asked in such a way as to
introduce the application to respondents. 
Scientists are trying to use biotechnology and genetic engineering to change plants, in ways that may be
quicker than traditional programs, in order to make the plants more useful. For example, make these resis-
tant to diseases or pests, make them ripen faster or give them the ability to grow in dry or salty soils. Please
indicate to what extent you agree or disagree with each of the following statements concerning plant
research. “Such research is worthwhile and should be encouraged.” (EC, 1991, 1993) 
By 1996 the format had changed slightly: “And what do you think of taking genes from plant species and trans-
ferring them into crop plants, to make them more resistant to insect pests? To what extent do you agree or dis-
agree that this application [transferring genes from plants to crop plants] is risky for society?” (EC, 1997, 2000).
17 The available data for the US case are more problematic. The question regarding opinions of “biotechnology”
may confound views of both applications. The question regarding agricultural biotechnology is “willingness to
buy” rather than “support.” Moreover, the IFIC opinion series runs from 1997 to 2003, only three data points in
the media series.
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